Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Advances in Experimental Medicine and Biology|July 17, 2024
Transcription Factor TAL1 in ErythropoiesisJohannes Fechner, Jörn Lausen
Current Drug Targets|June 30, 2010
Molecular targeting of aberrant transcription factors in leukemia: strategies for RUNX1/ETOChristian Wichmann, Manuel Grez, Jörn Lausen
The Journal of Biological Chemistry|September 21, 2004
The nuclear receptor co-repressor (N-CoR) utilizes repression domains I and III for interaction and co-repression with ETOJörn Lausen, Seongeun Cho, Shaohua Liu, et al.
Plos One|October 3, 2013
The T-cell oncogene Tal2 Is a Target of PU.1 and upregulated during osteoclastogenesisNadine Courtial, Christian Mücke, Stefanie Herkt, et al.
The Journal of Biological Chemistry|December 24, 2009
Targets of the Tal1 transcription factor in erythrocytes: E2 ubiquitin conjugase regulation by Tal1Jörn Lausen, Ole Pless, Fransisca Leonard, et al.
Oncogene|July 12, 2005
HNF4alpha reduces proliferation of kidney cells and affects genes deregulated in renal cell carcinomaBelén Lucas, Karen Grigo, Silke Erdmann, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 13, 2011
Tal1 regulates osteoclast differentiation through suppression of the master regulator of cell fusion DC-STAMPNadine Courtial, Jeske J Smink, Olga N Kuvardina, et al.
The Journal of Biological Chemistry|July 24, 2008
G9a-mediated lysine methylation alters the function of CCAAT/enhancer-binding protein-betaOle Pless, Elisabeth Kowenz-Leutz, Maria Knoblich, et al.
Analytical Biochemistry|February 8, 2018
A coupled fluorescence-based assay for the detection of protein arginine N-methyltransferase 6 (PRMT6) enzymatic activityJan Kramer, Veronika Désor, Steffen Brunst, et al.
Pageof 3